Financial News
Achilles Therapeutics Plc (NQ: ACHL )
0.7415
+0.0015
(+0.20%)
Streaming Delayed Price
Updated: 3:58 PM EDT, Aug 23, 2024
Add to My Watchlist
All News about Achilles Therapeutics Plc
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://ml.globenewswire.com/media/72d930ff-8d50-41a7-a933-5bb41b0ca622/small/achilles-therapeutics-logo-rgb-small-jpg.jpg)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://ml.globenewswire.com/media/72d930ff-8d50-41a7-a933-5bb41b0ca622/small/achilles-therapeutics-logo-rgb-small-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/04/04/image49.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Achilles Therapeutics: Q1 Earnings Insights
May 10, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/04/04/image15.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Thursday's Intraday Session
April 04, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/04/04/image30.jpeg?width=1200&height=800&fit=crop)
Nasdaq Surges 1%; ConAgra Brands Posts Upbeat Earnings
April 04, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-federal-hall.jpg)
![](https://ml.globenewswire.com/media/72d930ff-8d50-41a7-a933-5bb41b0ca622/small/achilles-therapeutics-logo-rgb-small-jpg.jpg)
![](https://ml.globenewswire.com/media/72d930ff-8d50-41a7-a933-5bb41b0ca622/small/achilles-therapeutics-logo-rgb-small-jpg.jpg)
![](https://ml.globenewswire.com/media/72d930ff-8d50-41a7-a933-5bb41b0ca622/small/achilles-therapeutics-logo-rgb-small-jpg.jpg)
![](https://ml.globenewswire.com/media/72d930ff-8d50-41a7-a933-5bb41b0ca622/small/achilles-therapeutics-logo-rgb-small-jpg.jpg)
![](https://ml.globenewswire.com/media/72d930ff-8d50-41a7-a933-5bb41b0ca622/small/achilles-therapeutics-logo-rgb-small-jpg.jpg)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Exposures
Product Safety
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Thursday's After-Market Session
September 07, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/72d930ff-8d50-41a7-a933-5bb41b0ca622/small/achilles-therapeutics-logo-rgb-small-jpg.jpg)
![](https://ml.globenewswire.com/media/72d930ff-8d50-41a7-a933-5bb41b0ca622/small/achilles-therapeutics-logo-rgb-small-jpg.jpg)
Achilles Therapeutics to Present at Upcoming Conferences
June 12, 2023
Via GlobeNewswire
![](https://investorplace.com/wp-content/uploads/2022/10/stocks-to-buy-greedy1600-1024x576.png)
![](https://ml.globenewswire.com/media/72d930ff-8d50-41a7-a933-5bb41b0ca622/small/achilles-therapeutics-logo-rgb-small-jpg.jpg)
![](https://ml.globenewswire.com/media/72d930ff-8d50-41a7-a933-5bb41b0ca622/small/achilles-therapeutics-logo-rgb-small-jpg.jpg)
Via GlobeNewswire
![](https://ml.globenewswire.com/media/72d930ff-8d50-41a7-a933-5bb41b0ca622/small/achilles-therapeutics-logo-rgb-small-jpg.jpg)
![](https://ml.globenewswire.com/media/72d930ff-8d50-41a7-a933-5bb41b0ca622/small/achilles-therapeutics-logo-rgb-small-jpg.jpg)
![](https://ml.globenewswire.com/media/72d930ff-8d50-41a7-a933-5bb41b0ca622/small/achilles-therapeutics-logo-rgb-small-jpg.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.